CALL (949) 631-4780
New to the blog? These four answer the questions patients ask most:
EVO ICL vs LASIK: Which Procedure Is Right for You? The complete comparison: corneas, prescriptions, dry eye, and reversibility.
EVO ICL Candidate Guide Who qualifies, who does not, and how Dr. Feinerman decides.
Dysfunctional Lens Syndrome vs. Cataracts Why vision changes after 45, and what actually fixes it.
LASIK Before Pregnancy or After Kids? The timing question, answered.
What do Light Adjustable Lens reviews really tell you? Dr. Feinerman pairs his patients’ own words with published data, the fair complaints, and who should choose another lens.
Dr. Feinerman explains the six findings that lead him to decline a premium lens, the measurement behind each one, and the lens or plan he recommends instead.
Mix and match IOLs place a different lens in each eye so the two work together. Dr. Feinerman explains the evidence, how he picks the pairing, and who should not get it.
Refractive lens exchange and cataract surgery are the same operation at different ages. Dr. Feinerman explains what the waiting years cost, and when waiting is the better choice.
The EAGLE trial found that removing the natural lens controlled angle-closure glaucoma better than laser iridotomy. Dr. Feinerman explains what the trial did, what it found, and where it applies to farsighted patients over 50.
The Light Adjustable Lens costs $6,350 per eye as a lens upgrade when insurance covers your cataract surgery, $8,532 per eye for cataract surgery without insurance, and $8,270 per eye for refractive lens exchange. Here is what drives those numbers and what they include.
The real Light Adjustable Lens problems are the demands it makes on your time: UV-protective glasses until lock-in, extra office visits, and a longer care period. Dr. Feinerman explains each one, who is not a candidate, and what the published data and his own 2025 results show.
A toric IOL predicts your astigmatism correction before surgery. The Light Adjustable Lens sets it after healing. Dr. Feinerman compares the FDA study numbers and his own 2025 results.
US laser vision correction volume is down 52 percent since 2022 while EVO ICL adoption rose 76 percent. Dr. Feinerman explains what is driving the shift, where LASIK still belongs, and what it means for your eyes.
This quiz is educational and does not diagnose any condition or guarantee candidacy for any procedure. Candidacy is determined only by a comprehensive evaluation, including corneal imaging and a full eye exam, performed by Gregg Feinerman, MD, FACS. Feinerman Vision · 320 Superior Ave, Suite 390, Newport Beach, CA 92663 · (949) 631-4780 · FeinermanVision.com